In contrast to anti TNF agents, IBD patients being treated with vedolizumab vaccine efficiency seem to not be affected after vaccination against influenza and hepatitis B [34,35], possibly due to its selective mechanism of action as antibody against the α4β7 integrin, which is mainly expressed in the gut [36]. This evidence concerns the gene TNF and hepatitis B virus infection.